Epidemiology and costs of hospital care for COPD in Puglia
- PMID: 22958809
- PMCID: PMC3463085
- DOI: 10.1186/2049-6958-6-5-299
Epidemiology and costs of hospital care for COPD in Puglia
Abstract
Background and aims: Chronic obstructive pulmonary disease (COPD) is currently the 5th cause of morbidity and mortality in the developed world and represents a substantial economic and social burden. The aim of this study is to report on hospital admissions and related costs of hospital treatment for COPD in the Puglia Region of Italy in the years 2005-2007.
Materials and methods: Patients were selected who were hospitalized between 01/01/2005 and 31/12/2007 with ICD-9-CM code: 490.xx: bronchitis not specified as acute or chronic; 491.xx: chronic bronchitis; 492.xx: emphysema; 493.xx: asthma; 494.xx: bronchiectasis; 496.xx: chronic airway obstruction not elsewhere classified; 518.81: acute respiratory failure as principal or secondary diagnosis.
Results: In the period 2005-2007, there were 73,721 hospital admissions for COPD registered in Puglia (25,690 in 2005; 24,153 in 2006 and 23,878 in 2007) of which 34.3% were women, with no significant variation in the three years. There appears to be a negative trend in hospitalisations in Puglia for chronic bronchitis with ratios decreasing from 359.4 per 100,000 population in 2005 to 307.9 per 100,000 in 2007. The overall cost of COPD for Apulian hospital trusts was €272,293,182.85 over the 3-year period.
Conclusions: Analysis of the data for hospital care, its costs and performance may be an important indicator of the efficacy of community care. In particular, the lack of reduction in admissions for COPD should lead decision makers to question both the appropriateness and quality of the care given.
Similar articles
-
Hospitalisation for COPD in Puglia: the role of hospital discharge database to estimate prevalence and incidence.Monaldi Arch Chest Dis. 2008 Sep;69(3):94-106. doi: 10.4081/monaldi.2008.386. Monaldi Arch Chest Dis. 2008. PMID: 19065843
-
Adherence to GOLD guidelines in real-life COPD management in the Puglia region of Italy.Int J Chron Obstruct Pulmon Dis. 2018 Aug 15;13:2455-2462. doi: 10.2147/COPD.S157779. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 30147311 Free PMC article.
-
Trends in the mortality of chronic obstructive pulmonary disease in Taiwan, 1981-2002.J Formos Med Assoc. 2005 Feb;104(2):89-93. J Formos Med Assoc. 2005. PMID: 15765162
-
Epidemiology of chronic obstructive pulmonary disease (COPD).Respiration. 2001;68(1):4-19. doi: 10.1159/000050456. Respiration. 2001. PMID: 11223724 Review.
-
Proton pump inhibitors for chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2020 Aug 25;8(8):CD013113. doi: 10.1002/14651858.CD013113.pub2. Cochrane Database Syst Rev. 2020. PMID: 32844430 Free PMC article.
Cited by
-
Effects of Budesonide Combined with Noninvasive Ventilation on PCT, sTREM-1, Chest Lung Compliance, Humoral Immune Function and Quality of Life in Patients with AECOPD Complicated with Type II Respiratory Failure.Open Med (Wars). 2019 Mar 2;14:271-278. doi: 10.1515/med-2019-0023. eCollection 2019. Open Med (Wars). 2019. PMID: 30886898 Free PMC article.
-
Outcomes and costs of treating chronic obstructive pulmonary disease with inhaled fixed combinations: the Italian perspective of the PATHOS study.Int J Chron Obstruct Pulmon Dis. 2014 Jun 5;9:569-76. doi: 10.2147/COPD.S65693. eCollection 2014. Int J Chron Obstruct Pulmon Dis. 2014. PMID: 24940053 Free PMC article.
-
Trends in health care resource utilization and pharmacological management of COPD in Taiwan from 2004 to 2010.Int J Chron Obstruct Pulmon Dis. 2017 Sep 28;12:2787-2793. doi: 10.2147/COPD.S147968. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 29026296 Free PMC article.
References
-
- Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med. 1995;152(5 Pt 2):S77S121. - PubMed
-
- WHO. WHO. World Health Statistics; 2008. COPD predicted to be third leading cause of death in 2030.http://www.who.int/whosis/whostat/2008/en/index.html
-
- Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, Jensen RL, Marks GB, Gulsvik A, Nizankowska-Mogilnicka E. BOLD Collaborative Research Group. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370:741–750. doi: 10.1016/S0140-6736(07)61377-4. - DOI - PubMed
LinkOut - more resources
Full Text Sources